www.phaseforward.com

solutions:

• IP Application Accelerator

• 10x improvement in application throughput
• 3.5x reduction in network latency
• Higher customer and end-user satisfaction
• Improved productivity for Global Customer Care Group

Waltham-based Phase Forward Incorporated (NASDAQ: PFWD) is a leading provider of integrated data collection and data management solutions for clinical trials and drug safety. Over 290 life sciences companies, medical device firms, regulatory agencies, and public health organizations in more than 110 countries use the company’s suite of products and services. Its award-winning InForm™ offering is an Internet-based electronic data capture (EDC) solution that collects and manages patient information in clinical trials.

As more life sciences companies conduct global clinical trials to maximize patient enrollment, Phase Forward has seen movement away from traditional client server-based applications. In fact, its Web-based eClinical, trial management and safety solutions are being rapidly adopted around the world. While Web-based applications are easier to access and maintain globally, response times can vary greatly due to fluctuations in worldwide Internet traffic and the unpredictable quality of public Internet infrastructure. "Akamai offered the only real solution to address Web application performance issues and the challenges unique to delivering applications worldwide. And it fit with Phase Forward's strategy of using best-of-breed technologies. Akamai conducted a proof-of-concept test of its IP Application (IPA) Accelerator and China CDN solutions for Phase Forward. The results were too compelling to ignore. The combination of IPA Accelerator and China CDN enables us to address much of our network latency issues, including the special challenges seen in countries such as China. Akamai's IP Application Accelerator technology gives us better and more reliable performance, especially in the more remote areas of the world. Now we can focus on other areas of the business. Akamai helps us deliver a better experience for both our customers and their end users. Because participants are able to enter data into our system more quickly, the entire clinical trial process is accelerated," says Deyermond.